Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
M Zeng, J Xia, Z Zong, Y Shi, Y Ni, F Hu, Y Chen… - Journal of Microbiology …, 2023 - Elsevier
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
F Barbier, S Hraiech, S Kernéis, N Veluppillai… - Annals of Intensive …, 2023 - Springer
Background Healthcare-associated infections involving Gram-negative bacteria (GNB) with
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience
A Marino, S Pulvirenti, E Campanella, S Stracquadanio… - Antibiotics, 2023 - mdpi.com
Ceftazidime/avibactam (CAZ/AVI) is an antibiotic combination approved for the treatment of
several infections caused by multi-drug resistant (MDR) Gram-negative bacteria. Neonates …
several infections caused by multi-drug resistant (MDR) Gram-negative bacteria. Neonates …
In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem …
Introduction Carbapenem-resistant Enterobacterales (CRE) and multidrug-resistant
Pseudomonas aeruginosa (MDR-PA) infections are associated with a high risk of morbidity …
Pseudomonas aeruginosa (MDR-PA) infections are associated with a high risk of morbidity …
Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization
F Cogliati Dezza, S Covino, F Petrucci… - JAC-Antimicrobial …, 2023 - academic.oup.com
Background Among MDR bacteria, carbapenem-resistant Acinetobacter baumannii (CRAB)
is a major concern due to the limited therapeutic options. During the COVID-19 pandemic, a …
is a major concern due to the limited therapeutic options. During the COVID-19 pandemic, a …
[HTML][HTML] Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety
Donor-derived infections (DDIs) caused by carbapenem-resistant gram-negative bacteria
(CR-GNB) in solid organ transplant recipients are potentially life-threatening. In this …
(CR-GNB) in solid organ transplant recipients are potentially life-threatening. In this …
[HTML][HTML] Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin
J Findlay, R Sierra, OHF Raro… - Journal of Global …, 2023 - Elsevier
Objectives Fosfomycin is a first-line treatment for uncomplicated urinary tract infections
(UTIs) in several European countries, and it is increasingly becoming the treatment of choice …
(UTIs) in several European countries, and it is increasingly becoming the treatment of choice …
[HTML][HTML] Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of …
A Oliva, D Al Ismail, G Arcari, MC Miele, E Casali… - Journal of Global …, 2023 - Elsevier
Objectives Little is known regarding outcomes and optimal therapeutic regimens of
infections caused by Klebsiella pneumoniae carbapenemase-producing Klebsiella …
infections caused by Klebsiella pneumoniae carbapenemase-producing Klebsiella …
Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae Infections: A …
A Oliva, L Campogiani, G Savelloni… - Open Forum …, 2023 - academic.oup.com
Abstract Background Recently, Klebsiella pneumoniae carbapenemase (KPC)–producing
Klebsiella pneumoniae (KPC-Kp) with resistance to ceftazidime/avibactam (CZA-R) has …
Klebsiella pneumoniae (KPC-Kp) with resistance to ceftazidime/avibactam (CZA-R) has …
The use of intravenous fosfomycin in clinical practice: a 5-year retrospective study in a tertiary hospital in Italy
A Anastasia, S Bonura, R Rubino, GM Giammanco… - Antibiotics, 2023 - mdpi.com
Fosfomycin in intravenous (IV) formulation has re-emerged as a valuable tool in the
treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections …
treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections …